# CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr

> **NCT06331013** · NA · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 60 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** CyberKnife ultra-hypofractionated SBRT

## Key facts

- **NCT ID:** NCT06331013
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-20
- **Primary completion:** 2025-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06331013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06331013, "CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06331013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*